A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
Clinical trial NCT07357415 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07357415
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-24
- Primary completion
- 2028-10-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.